HEALTHSTAT NEWS
STAT+: At ASCO, talk of barriers to cancer care, new treatments, and other big takeaways
The ASCO meeting highlighted discussions on barriers to cancer care and new treatments, including Brian Wolpin's presentation on the daraxonrasib pancreatic cancer study, which received a sustained standing ovation. The article concludes with a farewell from Chicago and an invitation to a virtual recap.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Pharmalittle: We’re reading about pancreatic and lung cancer drugs, China biotech growth, and more
- STAT+: A turning point for pancreatic cancer patients
- CBS News Things That Matter: A Town Hall with Ben Sasse
- A Deadly Cancer Is Seeing Real Progress
- FDA expands access to drug helping pancreatic cancer patients
- Pancreatic cancer patient Ben Sasse sees 'massive' tumor reduction with experimental new drug